Advertisment
|
|
news roundup
Janssen Research & Development announced that it has created the Integrated Smart Trial & Engagement Platform, an information technology toolset developed to automate investigational product supply and data management in clinical trials.
| advertisment
Tomorrow's Clinical Trial, Powered by Modern EDC
See how to cut study build time in half, eliminate migrations, and remove the need for source data verification (SDV).
 See a preview and watch the full webinar here. |
The Clinical Trials Transformation Initiative announced new recommendations aimed at reducing high rates of turnover among U.S. clinical trial site investigators and broadening the pool of qualified investigators.
| |
|
advertisment
|
|
|
Advertisment
|
|
| advertisment
ERT Video Series
Check out the ERT video series, filmed on the show floor at DIA 2017, for interviews on Innovating Clinical Trial Management, eCOA in Clinical Research: Trends and Advances, and Optimizing Clinical Trial Imaging through Advanced Technology.
 Click here to watch all 10 short videos |
Novaseek’s Clinical Data Network for Research (CDNR) platform is a cloud-based platform that scans for laboratory biospecimens that match researchers’ detailed clinical criteria, automating what was once a manual process of biospecimen selection and chart reviews and will be used with hc1.com’s healthcare relationship management (HRM) platform to reach hospitals and clinical labs.
| advertisment
Navigating the Regulatory Complexities of Orphan Drugs: Know the unwritten rules of designations and what's next
Live Webinar: Thursday, November 2 at 11:00am EDT
 Register now |
SGS has entered into collaboration with Bavarian Nordic A/S, an international biotechnology company specializing in vaccines, to develop a new respiratory syncytial virus (RSV) challenge strain, to help advance a vaccine in RSV A&B.
| advertisment
Future-proofing your Pharmacovigilance Delivery Model: Achieving scalability and cost effectiveness with AI/smart machines
Live Webinar: Wednesday, October 25 at 11:00am EDT
 Register now |
|
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
| advertisment
Rare disease trials differ from those in most other therapeutic areas because the indications are more complex and involve smaller patient populations. In a series of white papers, PRA experts discuss the barriers drug developers face when positioning a new trial in the rare disease space and how to minimize these while engaging with the right patients.
 Read more |
| advertisment
Rare Diseases and the Eye - Envisioning Strategies for Success
Live Webcast: Friday, October 27 at 11:00am EDT
 Register now |
|
Articles
This section explores how big data is setting the stage for increased R&D collaboration, as well as steps to take to increase the possibility of success for those collaborations.
| advertisment
RBM Technology Impact on Clinical Roles: Centralized Monitoring is streamlining activities and changing roles across clinical development
Live Webinar: Wednesday, October 18 at 11:00am EDT
 Register now |
This article explores a well-defined strategy for importation processes to ensure a continuous supply chain for clinical trials in Latin American countries.
| advertisment
Clinical Trial Simulation: An Efficient Tool for Improved Study Designs, Dose Selection and Go/No-go Investment Decisions
On Demand
 Learn more |
|
|
|
Blog Posts
FDA analysts report in a study involving interviews with primary care physicians and endocrinologists across the U.S., that many doctors could not correctly define “randomized controlled trial,” and that majorities did not fully understand terms such as “re-randomization” and “non-inferiority randomized controlled trial.”
| advertisment
Proactive Planning, a Transformational Revolution to Improving Clinical Trial Quality?
On Demand
 Learn more |
The Duke Margolis Center for Health Policy (DMCHP) recently collaborated with the FDA to release an mHealth action plan entitled Mobilizing mHealth Innovation for Real-World Evidence Generation.
| advertisment
Accelerate NASH Development: Next-generation Approaches to Overcome Recruitment and Study Execution Challenges
On Demand
 Learn more |
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
